Individuals may face a number of impediments to receiving optimal cancer care, including a lack of clear understanding of all treatment options, transportation, social support, insurance/financial concerns, and problems communicating with healthcare providers.
As more and more people are being diagnosed with cancer, and fewer and fewer medical students/navigators are choosing to go into the field of oncology, burnout is a risk for all of us.
Our AONN+ chapter formed as a few nurse navigators were getting together occasionally after work to share ideas and support each other. This grew into a plan to launch a state chapter of AONN+ after learning how simple it would be to start.
The U.S. Food and Drug Administration has granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications.
Clinical trials are important because they help to study new ways to treat, diagnose, and prevent cancer, as well as manage symptoms and side effects from cancer treatment.
I fantasize that one day my granddaughter, who just turned 7, will be the generation that will find “cancer” listed in the chapter entitled “cured diseases.” Is that possible? I hope so.
The AONN+ upstate chapter was formed after a discussion at the AONN+ national meeting on developing a local chapter. Kirsten Beeker was extremely enthusiastic and the main driver of the chapter development.
Working with patients dealing with challenging medical conditions can be meaningful for many healthcare professionals. It can also lead to frustration and burnout.
During as well as after national oncology conferences, the media releases information to consumers that tantalizes their interest in staying up to watch the late night news.
